The report on the Global Nuclear Medicine / Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Study period considered for research of global nuclear medicine/radiopharmaceuticals market:
- Base Year: 2019
- Estimated Year: 2020
- Forecast Till: 2026
A glimpse of the major drivers and restraints affecting the nuclear medicine/radiopharmaceuticals market is mentioned below:
Drivers
- Increase in the number of new cancer cases
- Rising adoption of SPECT and PET Scans
- Increase in preference for radiation therapy for cancer treatment
- Developments in imaging technologies using radiopharmaceuticals
Restraints
- Stringent regulatory policies
- Competition from conventional alternative diagnostic procedures
The report offers a value chain analysis that gives a comprehensive outlook of the nuclear medicine/radiopharmaceuticals market. The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.
The nuclear medicine/radiopharmaceuticals market has been segmented based on product types such as diagnostic and therapeutic products. Diagnostics products market is further analyzed based on SPECT and PET isotopes. Whereas, therapeutics market is divided into alpha emitters, beta emitters, and brachytherapy. The study incorporates periodic market estimates and forecasts. Each product type has been analyzed based on the market size at regional and country levels.
The nuclear medicine/radiopharmaceuticals market has been segmented based on cardiology, neurology, oncology, thyroid, bone metastasis, and endocrine tumors. The report provides forecast and estimates for each application in terms of market size during the study period. Each application has been further analyzed based on regional and country levels.
Geographically, the nuclear medicine/radiopharmaceuticals market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The study details country-level aspects based on each segment and gives estimates in terms of market size.
The report also covers the complete competitive landscape of the global Nuclear Medicine / Radiopharmaceuticals market with company profiles of key players such as:
- Bayer Healthcare AG
- Cardinal Health, Inc.
- Eczacibasi-Monrol Nuclear Products
- GE Healthcare
- IBA Molecular Imaging
- Jubilant Pharma
- Mallinckrodt plc
- Medtronic plc
- Nordien, Inc.
- Siemens Healthcare
- Sigma Aldrich Corporation
A detailed description of each has been included, with information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments. This analysis gives a thorough idea about the competitive positioning of market players. The report also gives information of nuclear medicine/radiopharmaceuticals market’s mergers/acquisitions, partnerships, collaborations, new product launches, new product developments and other industry developments.
SEGMENTATIONS IN REPORT:
Nuclear Medicine/Radiopharmaceuticals Market Analysis by Product Type:
- Diagnostics
- SPECT Isotopes
- PET Isotopes
- Therapeutics
- Alpha Emitters
- Beta Emmiters
- Brachytherapy
Nuclear Medicine/Radiopharmaceuticals Market Analysis by Applications:
- Cardiology
- Neurology
- Oncology
- Thyroid
- Bone Metastasis
- Endocrine Tumors
Nuclear Medicine/Radiopharmaceuticals Market Analysis by Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East And Africa
The Global Nuclear Medicine / Radiopharmaceuticals Market has been exhibited in detail in the following chapters -
Chapter 1 Nuclear Medicine / Radiopharmaceuticals Market Preface
Chapter 2 Executive Summary
Chapter 3 Nuclear Medicine / Radiopharmaceuticals Industry Analysis
Chapter 4 Nuclear Medicine / Radiopharmaceuticals Market Value Chain Analysis
Chapter 5 Nuclear Medicine / Radiopharmaceuticals Market Analysis By Product Type
Chapter 6 Nuclear Medicine / Radiopharmaceuticals Market Analysis By Applications
Chapter 7 Nuclear Medicine / Radiopharmaceuticals Market Analysis By Geography
Chapter 8 Competitive Landscape Of Nuclear Medicine / Radiopharmaceuticals Companies
Chapter 9 Company Profiles Of Nuclear Medicine / Radiopharmaceuticals Industry
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.